Zelegent, Inc. (formerly Snorx, Inc.), is a medical technology company that is developing, and plans to manufacture and market innovative tools for physicians who treat sleep disorders. Zelegent was co-founded by two of the world’s foremost authorities on sleep disorders, Dr. Yosef P. Krespi who heads the New York Head and Neck Institute Sleep Disorder Center, and Dr. David O. Volpi, founder of the eOs Sleep Network (formerly the Manhattan Sleep Center). The company’s mission is to develop and commercialize a novel minimally-invasive surgical tool to be used by sleep specialist otolaryngologists to treat snoring by shortening, suspending, and stiffening the patient’s soft palate, the source of most snoring. The Zelegent tool is an investigational device only and is not for sale in the United States.